Pankaj Jain
Has grant
Clinical Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Improving the safety of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) to reduce mortality in cardiogenic shock: a biventricular mock loop study.
Open Date: 2024-02-01
Close Date: 2025-02-01
Grant: Open
Evaluation of a Standardised Clinical Pathway to Improve Equity and Outcomes in Cardiogenic Shock: ESCAPE-CS
Open Date: 2023-01-01
Close Date: 2026-12-01
Grant: Close
Recovery of heart function after insertion of a mechanical pump
Open Date: 2017-02-01
Close Date: 2019-12-01
Articles (16)
Year:
2026
BACKGROUND: Coronary artery spasm (CAS) is a common cause of angina with nonobstructive coronary arteries (ANOCA). While acetylcholine provocation testing is the diagnostic gold standard, protocol variations have led to discrepancies in diagnostic accuracy. This study aimed to compare the diagnostic validity of conventional versus high-dose acetylcholine regimens in patients with ANOCA. METHODS: Multivessel acetylcholine provocation testing was systematically performed in patients with ANOCA and a control cohort undergoing invasive coronary angiography for noncoronary indications. Incremental acetylcholine doses in the left (20–200 μg) and right (20–80 μg) coronary arteries were manually injected over 20 seconds to induce CAS. RESULTS: The study included 62 patients with ANOCA with typical CAS symptoms and 20 controls. Conventional-dose acetylcholine testing identified CAS in 67.1% (55/82) of patients, while high-dose testing detected CAS in 79.3% (65/82). Among patients with inducible spasm, 93.4% (61/65) had typical angina consistent with CAS. High-dose acetylcholine demonstrated significantly higher sensitivity (98% versus 87%, P =0.008), but a nonsignificant trend toward lower specificity (80% versus 95%, P =0.08). The high-dose regimen also showed a higher negative predictive value (94% versus 70%, P =0.01), while positive predictive values were comparable (93% versus 98%, P =0.12). CONCLUSIONS: High-dose acetylcholine provocation improves the detection of CAS in patients with ANOCA but may increase the risk of overdiagnosis. This approach should be reserved for patients with a high clinical suspicion of CAS, with the results interpreted within the broader clinical context.
Year:
2025
Year:
2025
Year:
2025
Background and aims: The effect of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) on left atrial pressure (LAP) in the presence of interventricular interaction and the Frank–Starling mechanism is unknown. We developed and validated a mock circulatory loop (MCL) incorporating a novel, 3D-printed biventricular heart model and Frank–Starling algorithm, and used this model to assess the determinants of LAP during VA-ECMO support. Methods: The MCL was designed to allow a separate ventricle or biventricular configuration, with or without an active Frank–Starling mechanism. The biventricular model with Frank–Starling mechanism was validated in terms of (1) the presence and degree of ventricular interactions; (2) its ability to simulate Frank–Starling physiology; and (3) its capacity to simulate normal and pathological cardiac states. In the separate ventricle and biventricular with Frank–Starling models, we assessed the effect on LAP of changes in mean aortic pressure (mAoP), ECMO pump speed, LV contractility and ECMO return flow direction. Results: In the biventricular configuration, clamping RA inflow decreased RAP, with a concurrent decrease in LAP, consistent with direct ventricular interaction. With a programmed Frank–Starling mechanism, decreasing RAP was associated with a significant reduction in both LV outflow and LV end-systolic pressure. In the biventricular model with a Frank–Starling algorithm, the MCL was able to reproduce pre-defined normal and pathological cardiac output, and arterial and ventricular pressures. Increasing aortic pressure caused a linear increase in LAP in the separate ventricle model, which was attenuated in the biventricular model with Frank–Starling mechanism. Increasing ECMO pump speed caused no change in LAP in the separate ventricle model (p = 0.75), but significantly decreased LAP in the biventricular model with Frank–Starling mechanism (p = 0.039), with stabilization of LAP at the highest pump speeds. Changing the direction of VA-ECMO return flow did not affect LAP in either the separate ventricle (p = 0.91) or biventricular model with Frank–Starling mechanism (p = 0.76). Conclusions: Interventricular interactions and the Frank–Starling mechanism can be simulated in a physical, biventricular MCL. In their presence, the effects of VA-ECMO on LAP are mitigated, with LAP reduction and stabilization at maximal VA-ECMO speeds.
Year:
2025
Type 1 cardiorenal syndrome is associated with significant excess morbidity and mortality in patients with severe acute decompensated heart failure. Previous trials of vasoactive drugs and ultrafiltration have not shown superiority over placebo or intravenous diuretics. Pilot data suggest short-term mechanical support devices may support diuresis in the cardiorenal syndrome. We evaluated the intra-aortic balloon pump (IABP) and a novel intra-aortic entrainment pump (IAEP) in a mock circulation loop (MCL) biventricular systolic heart failure model, to assess impact on renal flow and cardiac hemodynamics. Both devices produced similar and only modest increase in renal flow (IABP 3.3% vs. IAEP 4.3%) and cardiac output, with associated reduction in afterload elastance in the MCL. There were minor changes in coronary flow, increase with IABP and minor decrease with IAEP. Differences in device preload and afterload did not impact percentage change in renal flow with IABP therapy, however, there was a trend toward higher percentage flow change with IAEP in response to high baseline renal flow. The IAEP performed best in a smaller aorta and with more superior positioning within the descending aorta. Demonstrated changes in MCL flow during IAEP were of lower magnitude than previous animal studies, possibly due to lack of autoregulation and hormonal responses.
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (9)
Kavitha Muthiah
Clinical Faculty - Mechanical Circulatory Support and Transplant Translational Laboratory
Victor Chang Cardiac Research Institute
Andy Yong
Macquarie University
Christopher Chi-Yuen Wong
Clinical Assistant Professor
The University of Hong Kong
Michael Stevens
Lecturer
UNSW Sydney
Audrey Adji
Senior Scientist
Victor Chang Cardiac Research Institute
Katherine Kearney
University of Texas Southwestern Medical Center
Brian Burns
faculty of medicine and health sciences macquarie university sydney nsw australia
Mark Dennis
University of Sydney
Scott William
Associate Lecturer
University of Wollongong
Make your next move.
Prepare your application
Review drafts before you send them.